Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FASTER
NCT00109382Phase 3Completed
- Sponsor
- University of Calgary
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of clopidogrel, simvastatin in Transient Ischemic Attack (TIA), stroke, sponsored by University of Calgary. Started May 2003; status: completed.
02
Drugs
clopidogrelsimvastatin
03
Conditions
Transient Ischemic Attack (TIA)stroke
Beyond the preview
Go deeper on NCT00109382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109382.